Transmembrane Stem Cell Factors as Potential Therapeutic Agent

Average stem cell factor has been limited due to toxicity in mast cell activation, but new research is suggesting that transmembrane stem cell factors may be a substitute that does not cause this toxicity. Being able to perform these therapies and acquire benefits without potential risk of toxicity is a wonderful opportunity that will give us more options to treat patients.

Learn more: https://www.nature.com/articles/s41467-022-30103-2